BR112016026074B1 - Métodos para formar compostos - Google Patents

Métodos para formar compostos Download PDF

Info

Publication number
BR112016026074B1
BR112016026074B1 BR112016026074-0A BR112016026074A BR112016026074B1 BR 112016026074 B1 BR112016026074 B1 BR 112016026074B1 BR 112016026074 A BR112016026074 A BR 112016026074A BR 112016026074 B1 BR112016026074 B1 BR 112016026074B1
Authority
BR
Brazil
Prior art keywords
formula
compound
alkyl
independently selected
occurrence
Prior art date
Application number
BR112016026074-0A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112016026074A8 (pt
Inventor
Andrea Faini
Marco Forzatti
Giovanni Fogliato
Stefano Biondi
Original Assignee
Allecra Therapeutics Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allecra Therapeutics Sas filed Critical Allecra Therapeutics Sas
Publication of BR112016026074A8 publication Critical patent/BR112016026074A8/pt
Publication of BR112016026074B1 publication Critical patent/BR112016026074B1/pt

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/87—Compounds being unsubstituted in position 3 or with substituents other than only two methyl radicals attached in position 3, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1896—Compounds having one or more Si-O-acyl linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
BR112016026074-0A 2014-05-15 2015-05-14 Métodos para formar compostos BR112016026074B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1408649.0A GB201408649D0 (en) 2014-05-15 2014-05-15 Method
GB1408649.0 2014-05-15
PCT/EP2015/060733 WO2015173378A2 (en) 2014-05-15 2015-05-14 Method

Publications (2)

Publication Number Publication Date
BR112016026074A8 BR112016026074A8 (pt) 2021-03-30
BR112016026074B1 true BR112016026074B1 (pt) 2023-01-03

Family

ID=51134924

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016026074-0A BR112016026074B1 (pt) 2014-05-15 2015-05-14 Métodos para formar compostos

Country Status (29)

Country Link
US (1) US9963465B2 (cg-RX-API-DMAC7.html)
EP (3) EP3143028B1 (cg-RX-API-DMAC7.html)
JP (1) JP6613303B2 (cg-RX-API-DMAC7.html)
KR (1) KR102329186B1 (cg-RX-API-DMAC7.html)
CN (1) CN106459086B (cg-RX-API-DMAC7.html)
AU (1) AU2015261416B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016026074B1 (cg-RX-API-DMAC7.html)
CA (1) CA2945900C (cg-RX-API-DMAC7.html)
CL (2) CL2016002880A1 (cg-RX-API-DMAC7.html)
CR (1) CR20160580A (cg-RX-API-DMAC7.html)
CY (2) CY1120957T1 (cg-RX-API-DMAC7.html)
DK (2) DK3143028T3 (cg-RX-API-DMAC7.html)
EA (2) EA201991629A3 (cg-RX-API-DMAC7.html)
EC (1) ECSP16085143A (cg-RX-API-DMAC7.html)
ES (2) ES2725675T3 (cg-RX-API-DMAC7.html)
GB (1) GB201408649D0 (cg-RX-API-DMAC7.html)
HR (2) HRP20182065T1 (cg-RX-API-DMAC7.html)
HU (1) HUE044511T2 (cg-RX-API-DMAC7.html)
IL (1) IL248834B (cg-RX-API-DMAC7.html)
LT (2) LT3231806T (cg-RX-API-DMAC7.html)
MX (1) MX378875B (cg-RX-API-DMAC7.html)
PE (1) PE20161433A1 (cg-RX-API-DMAC7.html)
PL (2) PL3143028T3 (cg-RX-API-DMAC7.html)
PT (2) PT3231806T (cg-RX-API-DMAC7.html)
RS (2) RS58748B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201609494YA (cg-RX-API-DMAC7.html)
SI (2) SI3231806T1 (cg-RX-API-DMAC7.html)
TR (1) TR201906867T4 (cg-RX-API-DMAC7.html)
WO (1) WO2015173378A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201319776D0 (en) * 2013-11-08 2013-12-25 Allecra Therapeutics Sas Compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1319776A (en) 1969-07-15 1973-06-06 Yorkshire Chemicals Ltd Basic dyes
WO2008010048A2 (en) * 2006-07-12 2008-01-24 Orchid Chemicals & Pharmaceuticals Limited Novel 2-substituted methyl penam derivatives
EA030662B1 (ru) * 2010-11-25 2018-09-28 Аллекра Терапойтикс Гмбх β-ЛАКТАМОВЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ β-ЛАКТАМАЗЫ И ИХ ПРИМЕНЕНИЕ
KR20120067257A (ko) * 2010-12-15 2012-06-25 서강대학교산학협력단 3-메틸-1,4-치환된 1,2,3-트라이아졸륨 기반의 이온성 액체 및 그의 제조방법과 응용

Also Published As

Publication number Publication date
ES2699644T3 (es) 2019-02-12
CA2945900A1 (en) 2015-11-19
CN106459086A (zh) 2017-02-22
SG11201609494YA (en) 2016-12-29
PL3143028T3 (pl) 2019-04-30
CL2016002880A1 (es) 2017-06-16
EA201692306A1 (ru) 2017-05-31
JP6613303B2 (ja) 2019-11-27
EA201991629A3 (ru) 2020-02-28
EP3231806A1 (en) 2017-10-18
IL248834B (en) 2019-05-30
WO2015173378A2 (en) 2015-11-19
PT3143028T (pt) 2018-12-17
EP3231806B1 (en) 2019-02-13
PE20161433A1 (es) 2017-01-18
KR102329186B1 (ko) 2021-11-22
AU2015261416B2 (en) 2019-07-11
US9963465B2 (en) 2018-05-08
HRP20190830T1 (hr) 2019-06-28
HRP20182065T1 (hr) 2019-02-08
GB201408649D0 (en) 2014-07-02
EP3441395A1 (en) 2019-02-13
BR112016026074A8 (pt) 2021-03-30
CR20160580A (es) 2017-05-09
HUE044511T2 (hu) 2019-10-28
CY1121756T1 (el) 2020-07-31
MX378875B (es) 2025-03-11
EP3143028B1 (en) 2018-09-26
NZ725121A (en) 2023-09-29
ES2725675T3 (es) 2019-09-26
WO2015173378A3 (en) 2016-01-14
CA2945900C (en) 2023-01-24
EA201991629A2 (ru) 2019-12-30
TR201906867T4 (tr) 2019-05-21
KR20170002466A (ko) 2017-01-06
US20170101421A1 (en) 2017-04-13
DK3231806T3 (da) 2019-05-20
JP2017515907A (ja) 2017-06-15
RS58430B1 (sr) 2019-04-30
RS58748B1 (sr) 2019-06-28
LT3143028T (lt) 2018-12-27
PT3231806T (pt) 2019-05-30
LT3231806T (lt) 2019-05-27
EA033494B1 (ru) 2019-10-31
EP3143028A2 (en) 2017-03-22
CL2018001961A1 (es) 2018-08-31
CN106459086B (zh) 2018-11-13
AU2015261416A1 (en) 2016-11-10
ECSP16085143A (es) 2017-05-31
SI3143028T1 (sl) 2019-01-31
PL3231806T3 (pl) 2019-08-30
MX2016014644A (es) 2017-02-23
DK3143028T3 (da) 2019-01-02
SI3231806T1 (sl) 2019-06-28
CY1120957T1 (el) 2019-12-11
IL248834A0 (en) 2017-01-31

Similar Documents

Publication Publication Date Title
AU2011333305B2 (en) Compounds and their use
JP7346485B2 (ja) 結晶性β-ラクタマーゼ阻害剤
JP6613303B2 (ja) ペナム化合物の製造方法
JP2003300985A (ja) セフェム化合物
HK1234738B (en) Methods for preparing penams
NZ725121B2 (en) Methods for Preparing Penams
HK1234738A1 (en) Methods for preparing penams
BR112016010282B1 (pt) Composição farmacêutica compreendendo um inibidor de betalactamase cristalino
JPH04338392A (ja) 新規セフェム誘導体及びその製造方法
IE883046L (en) Cephalosporin derivatives with improved pharmacokinetics, process for their preparation, pharmaceutical compositions in which they are present and synthesis intermediate

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/05/2015, OBSERVADAS AS CONDICOES LEGAIS